10 ml of tirzepatide - CellGenic Mounjaro (Tirzepatide) Injection 7.5 mg/0.5
Description
Decreased appetite or minor headaches as your calorie intake settles at a lower, healthier level
A shade of light orange says your body is craving more fluids
Biomarker assessment and genetic predispositions in peptide pathways may help support a more informed conversation about optimal injection timing for your specific situation
Approval: 2017 Injection: 2 mg/1.5 mL (1.34 mg/mL) available in: Single-patient-use pen that delivers 0.25 mg or 0.5 mg per injection
